A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
ROSE for Improved Molecular Marker Testing Via EBUS
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
SCION: SABR and Checkpoint Inhibition of NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial
- Status
- RECRUITING
- Phase
- PHASE2
Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)
- Status
- COMPLETED
- Phase
- NA
Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE2
MEOI and HRQoL in CLL Patients Treated With BTKis
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)
- Status
- COMPLETED
- Phase
- PHASE3
Vascular Impact of Dapagliflozin in CKD Patients (DAPAVASC)
- Status
- COMPLETED
- Phase
- PHASE2
Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE4
Exacerbations and Their Outcomes International (EXACOS International)
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death
- Status
- COMPLETED
- Phase
- PHASE4
Use of Exhaled Particles to Assess Lung Pharmacokinetics
- Status
- COMPLETED
- Phase
- NA
Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients
- Status
- COMPLETED
- Phase
- NA
Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)
- Status
- TERMINATED
- Phase
- PHASE2
The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap Patients
- Status
- COMPLETED
- Phase
- N/A